SEC Form 4 · accession 0001104659-16-127830
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R. King
Officer — Executive VP and Secretary
Period of report
Jun 14, 2016
Accepted (ET)
Jun 16, 2016 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F2,F3 | $5.09 | Jun 14, 2016 | A | 49,942 | A | — | Jul 2, 2025 | Common Stock | 49,942 | 49,942 | D |
| Stock option (right to buy)F1,F4,F3 | $1.58 | Jun 14, 2016 | A | 28,263 | A | — | Apr 1, 2026 | Common Stock | 28,263 | 28,263 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Stock Incentive Plan.
- F2The option grant was approved by the Issuer's board of directors on July 2, 2015, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on June 14, 2016.
- F3Vests in equal monthly installments such that it is vested in full on the 3-year anniversary of the grant date.
- F4The option grant was approved by the Issuer's board of directors on April 1, 2016, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on June 14, 2016.